For a complete overview of living well with GLP-1 medications, see our GLP-1 Lifestyle Guide
It is segmented geographically, with specific market dynamics for each region
Currently, there are many different GLP-1 agonists on the market, most of which are administered via injection
Efficacy Results At 24 weeks, the mean percentage change in body weight was: - Placebo: 1.6% - 1 mg: 7.2% - 4 mg (combined): 12.9% - 8 mg (combined): 17.3% - 12 mg: 17.5% At 48 weeks: - Placebo: 2.1% - 1 mg: 8.7% - 4 mg (combined): 17.1% - 8 mg (combined): 22.8% - 12 mg: 24.2% Let me put that in context
The active molecule and its GLP-1 receptor mechanism are the same, but formulation, oversight, and labeling differ
By activating glucagon-like peptide-1 (GLP-1) receptors, it reduces appetite, increases feelings of fullness, and aids in weight loss